ESSA Pharma Inc. (EPIX)
1.68
0.00 (0.00%)
At close: Mar 03, 2025, 3:59 PM
1.66
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST
ESSA Pharma Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 217.00 | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 118.49K | 121.79K | 109.46K | 110.32K | n/a | 34.49K | 46.15K | 66.18K | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | -118.49K | -121.79K | -109.46K | -110.32K | n/a | -34.49K | -46.15K | -65.96K | n/a | n/a | n/a | n/a |
| Operating Income | n/a | -32.13M | -35.34M | -36.91M | -23.12M | -12.15M | -10.8M | -11.65M | -19.64M | -9.31M | -1.82M | -1.36M | -1.94K |
| Interest Income | n/a | 5.55M | 1.74M | 235K | 559.72K | 26.25K | 42.73K | n/a | n/a | 618.25 | 217.00 | 1.31K | 1.42 |
| Pretax Income | n/a | -26.58M | -35.22M | -36.84M | -23.73M | -10.4M | -11.6M | -4.38M | -12.99M | -8.57M | -1.82M | -1.37M | -1.94K |
| Net Income | n/a | -26.58M | -35.1M | -36.81M | -23.45M | -10.44M | -11.63M | -4.5M | -13.14M | -8.57M | -1.82M | -1.37M | -1.94K |
| Selling & General & Admin | n/a | 10.81M | 12.54M | 12.78M | 11.37M | 5.47M | 5.93M | 5.14M | 5.64M | 3.7M | 1.04M | 371.18K | 298.27 |
| Research & Development | 21.21M | 21.32M | 24.41M | 24.26M | 12.15M | 6.7M | 4.87M | 5.73M | 13.06M | 4.39M | 671.6K | 1.59M | 1.76K |
| Other Expenses | n/a | n/a | 1.74M | 109.46K | 515K | 35K | -40K | -37K | 79K | 1.15M | n/a | n/a | n/a |
| Operating Expenses | 21.21M | 32.13M | 36.96M | 37.14M | 23.52M | 12.17M | 10.8M | 10.87M | 18.7M | 9.23M | 1.74M | 1.37M | 1.94K |
| Interest Expense | n/a | 6.94K | 14K | 22.22K | 618K | 603K | 912K | 785K | 938K | 77.77K | 87.59K | n/a | n/a |
| Selling & Marketing Expenses | n/a | 22.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.83K | 22.96 |
| Cost & Expenses | n/a | 32.13M | 36.96M | 37.14M | 23.52M | 12.17M | 10.8M | 10.87M | 18.7M | 9.23M | 1.74M | 1.37M | 1.94K |
| Income Tax | n/a | 1.6K | -112K | -34.35K | -289K | 38K | 27K | 116K | 151K | 77.77K | 87.59K | 0.28 | n/a |
| Shares Outstanding (Basic) | 44.28M | 44.09M | 44.04M | 38.48M | 22.44M | 8.43M | 4.57M | 1.45M | 1.35M | 917.65K | 784.38K | 784K | 732.00 |
| Shares Outstanding (Diluted) | 44.28M | 44.09M | 44.04M | 38.48M | 22.44M | 8.43M | 4.57M | 1.45M | 1.35M | 917.65K | 784.38K | 784.38K | 732.65 |
| EPS (Basic) | -0.64 | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
| EPS (Diluted) | -0.64 | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
| EBITDA | n/a | -26.46M | -35.08M | -36.71M | -23.01M | -12.13M | -10.77M | -3.55M | -18.67M | -9.38M | -1.76M | -1.34M | -1.91K |
| Depreciation & Amortization | n/a | 118.49K | 121.79K | 109.46K | 110.32K | 18.3K | 34.49K | 46.15K | 66.18K | 39.1K | 23.39K | 24.62K | 25.41 |